CODX vs PNR · rev $3.9M vs P/E 18, rev $4.08B
Co-Diagnostics, Inc. Common Stock (CODX) versus Pentair PLC (PNR) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Pentair PLC (PNR) is a specialty industrial machinery company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported PNR revenue for 2024-12-31 was $4.08B. Net income was $625.4M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
CODX currently screens at market cap $31.4M. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
Not investment advice. Open the CODX and PNR stock pages for the full models.
Not investment advice.